Clinical Trial Update: IM19 CAR-T Cell Therapy in Refractory Systemic Lupus Erythematosus (SLE) [NA]

View source ↗

Summary

This clinical trial update notes that IM19 CAR-T cell therapy is recruiting for patients with refractory Systemic Lupus Erythematosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• IM19 CAR-T Cell Therapy

Snippet

Sponsor: Peking University Third Hospital | Conditions: Refractory Systemic Lupus Erythematosus | NA | Status: RECRUITING